Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity

Redox Biol. 2019 Apr:22:101135. doi: 10.1016/j.redox.2019.101135. Epub 2019 Feb 5.

Abstract

The aggregation of α-synuclein (α-syn) into amyloid fibrils is a major pathological hallmark of Parkinson's disease (PD) and other synucleinopathies. The mechanisms underlying the structural transition of soluble and innocuous α-syn to aggregated neurotoxic forms remains largely unknown. The disordered nature of α-syn has hampered the use of structure-based protein engineering approaches to elucidate the molecular determinants of this transition. The recent 3D structure of a pathogenic α-syn fibril provides a template for this kind of studies. The structure supports the NAC domain being a critical element in fibril formation, since it constitutes the core of the fibril, delineating a Greek-key motif. Here, we stapled the ends of this motif with a designed disulfide bond and evaluated its impact on the conformation, aggregation and toxicity of α-syn in different environments. The new covalent link biases the native structural ensemble of α-syn toward compact conformations, reducing the population of fully unfolded species. This conformational bias results in a strongly reduced fibril formation propensity both in the absence and in the presence of lipids and impedes the formation of neurotoxic oligomers. Our study does not support the Greek-key motif being already imprinted in early α-syn assemblies, discarding it as a druggable interface to prevent the initiation of fibrillation. In contrast, it suggests the stabilization of native, compact ensembles as a potential therapeutic strategy to avoid the formation of toxic species and to target the early stages of PD.

Keywords: Amyloid; Disulfide bond; Parkinson's disease; Protein aggregation; α-synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs
  • Amino Acid Sequence
  • Amyloid / chemistry
  • Amyloid / metabolism
  • Amyloid / ultrastructure
  • Disulfides / chemistry
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Kinetics
  • Lipid Metabolism
  • Magnetic Resonance Spectroscopy
  • Mutation
  • Neurons / metabolism
  • Parkinson Disease / etiology
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology
  • Protein Aggregates*
  • Protein Aggregation, Pathological / metabolism*
  • Protein Conformation*
  • Solubility
  • alpha-Synuclein / chemistry*
  • alpha-Synuclein / genetics
  • alpha-Synuclein / metabolism*
  • alpha-Synuclein / ultrastructure

Substances

  • Amyloid
  • Disulfides
  • Protein Aggregates
  • alpha-Synuclein